ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

ASCO to form commission to study tobacco problem.

January 23, 2004